McNeil Michael D.
Known title: Chief Financial OfficerCIK: 0001737969
Associated companies
Transaction History
| SMTI | ▼ Sell | Tax Withholding | 2,324 | $72K | 8/19/2025 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 343 | $12K | 4/10/2025 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 378 | $12K | 4/10/2025 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 362 | $13K | 4/10/2025 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 527 | $18K | 4/10/2025 | View on chart |
| SMTI | ▲ Buy | Grant | 1,486 | $0 | 3/19/2025 | View on chart |
| SMTI | ▲ Buy | Grant | 5,037 | $0 | 2/25/2025 | View on chart |
| SMTI | ▲ Buy | Grant | 4,650 | $0 | 3/7/2024 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 687 | $27K | 3/1/2024 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 599 | $23K | 3/1/2024 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 391 | $13K | 2/1/2024 | View on chart |
| SMTI | ▲ Buy | Option Exercise | 1,000 | $6K | 4/12/2023 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 658 | $27K | 3/17/2023 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 532 | $22K | 3/17/2023 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 253 | $11K | 3/17/2023 | View on chart |
| SMTI | ▲ Buy | Grant | 4,217 | $0 | 3/2/2023 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 253 | $6K | 12/2/2022 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 865 | $27K | 12/2/2022 | View on chart |
| SMTI | ▲ Buy | Grant | 6,547 | $0 | 3/8/2022 | View on chart |
| SMTI | ▲ Buy | Grant | 3,106 | $0 | 12/22/2021 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 152 | $5K | 12/16/2021 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 864 | $39K | 12/16/2021 | View on chart |
| SMTI | ▼ Sell | Tax Withholding | 152 | $7K | 12/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Sanara Merger Faces New Regulatory Hurdle
The merger between MiMedx and Sanara MedTech has encountered a new regulatory obstacle. This development has caused SMTI shares to drop below a key support level for the first time in four months. The news highlights potential delays or complications in the deal's approval process.
Sanara Merger Faces New Regulatory Hurdle. The merger between MiMedx and Sanara MedTech has encountered a new regulatory obstacle. This development has caused SMTI shares to drop below a key support level for the first time in four months. The news highlights potential delays or complications in the deal's approval process.